Report cover image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Global Market Report 2025

Published Jun 17, 2025
Length 175 Pages
SKU # BRC20111121

Description

Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on paroxysmal nocturnal hemoglobinuria (pnh) treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for paroxysmal nocturnal hemoglobinuria (pnh) treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The paroxysmal nocturnal hemoglobinuria (pnh) treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Treatment Type: Complement C5 Inhibitors; Anti-Complement Component 5a Receptor (C5aR) Monoclonal Antibodies; Alternative Pathway Inhibitors; Hematopoietic Stem Cell Transplantation; Other Therapies

2) By Route Of Administration: Intravenous; Subcutaneous; Oral

3) By Market Availability: Approved; In Pipeline; Investigational

4) By End-Use: Hospitals; Specialty Clinics; Homecare Settings; Other End-Users

Subsegments:

1) By Complement : C5 InhibitorsEculizumab (Soliris); Ravulizumab (Ultomiris); Emerging C5 Inhibitors; Biosimilars Of C5 Inhibitors,

2) By Anti-Complement Component 5a Receptor Monoclonal Antibodies: Avacopan (Tavneos); Other Investigational C5aR mAbs; Monotherapy vs Combination Therapy; Clinical Trial Phase (Phase I, II, III)

3) By Alternative Pathway Inhibitors: C3 Inhibitors; Factor B Inhibitors; Factor D Inhibitors; Targeting Complement Amplification; Combination Therapies And Dual Inhibition

4) By Hematopoietic Stem Cell Transplantation (HSCT) : Autologous HSCT vs. Allogeneic HSCT; Pre-Transplant Conditioning Therapies; Post-Transplant Immunosuppressive Therapies

5) By Other Therapies: Immunosuppressive Therapy; Supportive Care; Anticoagulation Therapy; Gene Therapy

Companies Mentioned: F. Hoffmann-La Roche Ltd; AstraZeneca PLC; Novartis AG; Amgen Inc.; Mayo Clinic

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Characteristics
3. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Trends And Strategies
4. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Growth Rate Analysis
5.4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Total Addressable Market (TAM)
6. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Segmentation
6.1. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Complement C5 Inhibitors
Anti-Complement Component 5a Receptor (C5aR) Monoclonal Antibodies
Alternative Pathway Inhibitors
Hematopoietic Stem Cell Transplantation
Other Therapies
6.2. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous
Subcutaneous
Oral
6.3. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Approved
In Pipeline
Investigational
6.4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Homecare Settings
Other End-Users
6.5. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Sub-Segmentation Of Complement C5 Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Eculizumab (Soliris)
Ravulizumab (Ultomiris)
Research And Development (Pipeline Drugs)
Combination Therapies With Other Immunosuppressants
Long-Term Efficacy And Safety Profiles
6.6. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Sub-Segmentation Of Anti-Complement Component 5a Receptor (C5aR) Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Candidates In Development
Mechanism Of Action
Therapeutic Areas
Anca-Associated Vasculitis
Chronic Obstructive Pulmonary Disease (COPD)
Rheumatoid Arthritis
Systemic Lupus Erythematosus (SLE)
Safety And Adverse Events
Efficacy And Clinical Trial Outcomes
Future Directions For Development
6.7. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Sub-Segmentation Of Alternative Pathway Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
C3 Inhibitors
Factor B Inhibitors
Factor D Inhibitors
Targeting Complement Amplification
Combination Therapies And Dual Inhibition
Efficacy And Safety In Clinical Trials
6.8. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Sub-Segmentation Of Hematopoietic Stem Cell Transplantation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Autologous HSCT vs. Allogeneic HSCT
Pre-Transplant Conditioning Therapies:
Post-Transplant Immunosuppressive Therapies
Stem Cell Sources
Indications
Complications
Recent Advancements
6.9. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Sub-Segmentation Of Other Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunosuppressive Therapy
Supportive Care
Anticoagulation Therapy
Gene Therapy
7. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Regional And Country Analysis
7.1. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
8.1. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
9.1. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
9.2. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
10.1. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
11.1. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
11.2. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
12.1. Australia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
13.1. Indonesia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
14.1. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
14.2. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
15.1. Western Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
15.2. Western Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
16.1. UK Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
17.1. Germany Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
18.1. France Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
19.1. Italy Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
20.1. Spain Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
21.1. Eastern Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
21.2. Eastern Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
22.1. Russia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
23.1. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
23.2. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
24.1. USA Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
24.2. USA Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
25.1. Canada Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
25.2. Canada Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
26.1. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
26.2. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
27.1. Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
28.1. Middle East Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
28.2. Middle East Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
29.1. Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Overview
29.2. Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market, Segmentation By Market Availability, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Competitive Landscape And Company Profiles
30.1. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Competitive Landscape
30.2. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
31. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Other Major And Innovative Companies
31.1. Regeneron Pharmaceuticals
31.2. Cleveland Clinic Foundation
31.3. Johns Hopkins Medicine
31.4. Memorial Sloan Kettering Cancer Center
31.5. Stanford Health Care
31.6. University of California San Francisco (UCSF) Health
31.7. Emory Healthcare
31.8. Cedars-Sinai Medical Center
31.9. Duke University Health System
31.10. Mount Sinai Health System
31.11. Dana-Farber Cancer Institute
31.12. Swedish Orphan Biovitrum
31.13. Alnylam Pharmaceuticals
31.14. BioCryst Pharmaceuticals
31.15. Apellis Pharmaceuticals
32. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
34. Recent Developments In The Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market
35. Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market High Potential Countries, Segments and Strategies
35.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Treatment Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.